IE921392A1 - Pcp receptor ligands and the use thereof - Google Patents

Pcp receptor ligands and the use thereof

Info

Publication number
IE921392A1
IE921392A1 IE139292A IE921392A IE921392A1 IE 921392 A1 IE921392 A1 IE 921392A1 IE 139292 A IE139292 A IE 139292A IE 921392 A IE921392 A IE 921392A IE 921392 A1 IE921392 A1 IE 921392A1
Authority
IE
Ireland
Prior art keywords
iminomethano
dibenzo
dihydro
cycloheptene
compound
Prior art date
Application number
IE139292A
Other languages
English (en)
Inventor
Eckard Weber
John F W Keana
Peter Barmettler
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of IE921392A1 publication Critical patent/IE921392A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE139292A 1991-04-29 1992-07-01 Pcp receptor ligands and the use thereof IE921392A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69324491A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
IE921392A1 true IE921392A1 (en) 1992-11-04

Family

ID=24783901

Family Applications (1)

Application Number Title Priority Date Filing Date
IE139292A IE921392A1 (en) 1991-04-29 1992-07-01 Pcp receptor ligands and the use thereof

Country Status (8)

Country Link
EP (1) EP0587670A4 (de)
JP (1) JPH07500571A (de)
AU (1) AU1910792A (de)
CA (1) CA2109420A1 (de)
IE (1) IE921392A1 (de)
PT (1) PT100431B (de)
WO (1) WO1992019621A1 (de)
ZA (1) ZA923119B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508401A (en) * 1991-02-20 1996-04-16 American Home Products Corporation Substituted dibenzo[a,d]cycloheptene NMDA antagonists
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597433A (en) * 1968-08-19 1971-08-03 Ayerst Mckenna & Harrison 10,11 - dihydro - 5,10 - (iminomethano)-5h-dibenzo(a,d)cycloheptene and derivatives thereof
US4940789A (en) * 1989-10-10 1990-07-10 American Home Products Corporation 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents
US5508401A (en) * 1991-02-20 1996-04-16 American Home Products Corporation Substituted dibenzo[a,d]cycloheptene NMDA antagonists

Also Published As

Publication number Publication date
AU1910792A (en) 1992-12-21
PT100431A (pt) 1993-08-31
WO1992019621A1 (en) 1992-11-12
EP0587670A1 (de) 1994-03-23
EP0587670A4 (de) 1995-02-01
PT100431B (pt) 1999-08-31
ZA923119B (en) 1993-01-27
JPH07500571A (ja) 1995-01-19
CA2109420A1 (en) 1992-10-30

Similar Documents

Publication Publication Date Title
CA2050284C (en) Pcp receptor ligands and the use thereof
JP2656702B2 (ja) ペプチド性キヌクリジン
JP4584706B2 (ja) 中枢及び末梢神経系障害を治療するための方法及び組成物、並びにそれらに有用な新規の化合物
US6235736B1 (en) 3-anilino-2-cycloalkenone derivatives
HUT65831A (en) Process for producing substituted 3-amino-quinuclidine derivatives and pharmaceutically acceptable salts
JPH02101062A (ja) 新規化合物、その製法及びそれを含む医薬組成物
CA3121202A1 (en) Pyrrole and pyrazole compounds and methods of use thereof
JP2004501909A (ja) 抗けいれん薬としての置換フタリド類
US6017910A (en) PCP receptor ligands and the use thereof
US5968949A (en) Substituted hydroisoquinoline derivatives and their use as pharmaceuticals
US6844368B1 (en) Compounds useful in pain management
US6498196B1 (en) Compounds useful in pain management
FI88162B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sulfonyldekahydro-8h-isokino/2,1-g//1,6/naftyridiner, deras optiska isomerer samt farmaceutiskt godtagbara salter
IE921392A1 (en) Pcp receptor ligands and the use thereof
PL191091B1 (pl) Nowe związki indanolowe, zawierające je kompozycje farmaceutyczne oraz ich zastosowanie
PL154813B1 (en) Method of obtaining s enantiomeric derivatives of glutar amide
ITMI960245A1 (it) Derivati di 1-/2-(vinilsostituite)/-3,4-diidro-5h-2,3-benzodiazepine
CA1328866C (en) Pyrazolo-pyrrolo-pyrimidine-diones
PT90677B (pt) Processo para a preparacao de novas diazepinonas condensadas e de composicoes farmaceuticas que as contem
AU662730B2 (en) Neuroprotectant agents
EP1140790A1 (de) Oxoaminotetralin-derivate zur verwendung in der schmerzbehandlung
CA2563575C (en) Enantiomerically pure hexahydropyrrolocyclopentapyridine derivatives

Legal Events

Date Code Title Description
FC9A Application refused sect. 31(1)